2024 annual financial data
Cytosorbents 2024 Operating margin
Cytosorbents 2024 operating margin with verified reported values.
Direct answer
Operating margin was -46.22%.
Operating income was -16,452,000 USD and net income was -20,718,957 USD.
Operating cash flow was -14,427,809 USD.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,595,000 USD
- Operating income
- -16,452,000 USD
- Net income
- -20,718,957 USD
- Operating cash flow
- -14,427,809 USD